Candriam S.C.A. Nektar Therapeutics Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Nektar Therapeutics stock. As of the latest transaction made, Candriam S.C.A. holds 79,594 shares of NKTR stock, worth $93,124. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,594

Previous 79,594 -0.0%

Holding current value

$93,124

Previous $98,000 5.1%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$0.9 - $1.83 $71,634 - $145,657	79,594 New	79,594 $98,000
Q4 2022 Feb 13, 2023	SELL	$2.03 - $4.28 $182,699 - $385,200	-90,000 Reduced 13.12%	595,938 $1.35 Million
Q1 2022 May 13, 2022	BUY	$4.16 - $13.72 $2.85 Million - $9.41 Million	685,938 New	685,938 $3.7 Million
Q2 2021 Jul 20, 2021	SELL	$16.52 - $20.4 $5.06 Million - $6.24 Million	-306,085 Closed	0 $0
Q4 2020 Jan 22, 2021	SELL	$15.77 - $19.03 $155,239 - $187,331	-9,844 Reduced 3.12%	306,085 $5.2 Million
Q2 2020 Jul 23, 2020	SELL	$16.86 - $23.44 $1.18 Million - $1.64 Million	-70,071 Reduced 18.15%	315,929 $7.32 Million
Q4 2019 Jan 21, 2020	SELL	$15.87 - $23.12 $63,480 - $92,480	-4,000 Reduced 1.03%	386,000 $8,000
Q3 2019 Oct 21, 2019	SELL	$16.91 - $36.27 $325,466 - $698,088	-19,247 Reduced 4.7%	390,000 $7,000
Q2 2019 Aug 01, 2019	SELL	$31.0 - $36.3 $605,864 - $709,447	-19,544 Reduced 4.56%	409,247 $14.5 Million
Q1 2019 May 02, 2019	SELL	$31.58 - $46.35 $549,965 - $807,185	-17,415 Reduced 3.9%	428,791 $14.4 Million
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $228,346 - $425,101	7,504 Added 1.71%	446,206 $14.7 Million
Q3 2018 Nov 07, 2018	BUY	$46.46 - $68.49 $14 Million - $20.7 Million	301,921 Added 220.73%	438,702 $26.7 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $6.33 Million - $14.3 Million	136,781 New	136,781 $6.68 Million
Q1 2018 May 09, 2018	SELL	$57.4 - $108.44 $9.24 Million - $17.5 Million	-161,000 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$23.02 - $60.5 $2.28 Million - $5.98 Million	-98,900 Reduced 38.05%	161,000 $9.62 Million
Q3 2017 Nov 03, 2017	BUY	$17.79 - $24.0 $4.62 Million - $6.24 Million	259,900	259,900 $6.24 Million

Others Institutions Holding NKTR

# of Institutions

147

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account